A fully human anti-IL-7Rα antibody promotes antitumor activity against T-cell acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

A fully human anti-IL-7Rα antibody promotes antitumor activity against T-cell acute lymphoblastic leukemia

Published:2019-03-08 Issue:9 Volume:33 Page:2155-2168
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Akkapeddi Padma,Fragoso Rita,Hixon Julie A.,Ramalho Ana Sofia,Oliveira Mariana L.,Carvalho Tânia,Gloger Andreas,Matasci Mattia,Corzana Francisco,Durum Scott K.,Neri Dario,Bernardes Gonçalo J. L.,Barata João T.

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

EC | European Research Council

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-019-0434-8.pdf

Reference60 articles.

1. Pui C-H, Jeha S. New therapeutic strategies for the treatment of acute lymphoblastic leukaemia. Nat Rev Drug Discov. 2007;6:149–65.

2. Puel A, Ziegler SF, Buckley RH, Leonard WJ. Defective IL7R expression in T-B + NK + severe combined immunodeficiency. Nat Genet. 1998;20:394–7.

3. Cao X, Shores EW, Hu-Li J, Anver MR, Kelsail BL, Russell SM, et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain. Immunity. 1995;2:223–38.

4. Rich BE, Campos-Torres J, Tepper RI, Moreadith RW, Leder P. Cutaneous lymphoproliferation and lymphomas in interleukin 7 transgenic mice. J Exp Med. 1993;177:305–16.

5. Abraham N, Ma MC, Snow JW, Miners MJ, Herndier BG, Goldsmith MA. Haploinsufficiency identifies STAT5 as a modifier of IL-7-induced lymphomas. Oncogene. 2005;24:5252–7.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The IL-7R antagonist lusvertikimab reduces leukemic burden in xenograft ALL via antibody-dependent cellular phagocytosis;Blood;2024-06-27

2. Selenium chemistry for spatio-selective peptide and protein functionalization;Nature Reviews Chemistry;2024-02-22

3. The Therapeutic Values of IL-7/IL-7R and the Recombinant Derivatives in Glioma: A Narrative Review;Journal of Interferon & Cytokine Research;2023-08-01

4. Emerging Epigenetic and Posttranslational Mechanisms Controlling Resistance to Glucocorticoids in Acute Lymphoblastic Leukemia;HemaSphere;2023-06-22

5. An Update on Clinical Trials and Potential Therapeutic Strategies in T-Cell Acute Lymphoblastic Leukemia;International Journal of Molecular Sciences;2023-04-13